CoChat

Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients

Rickels, Michael R., Schutta, Mark H., Mueller, Rebecca, Kapoor, Shiv, Markmann, James F., Naji, Ali, Teff, Karen L. · 2007 · The Journal of Clinical Endocrinology & Metabolism
Cited by 59

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

CONTEXT: In patients with type 1 diabetes and reduced awareness of hypoglycemia, the glycemic thresholds for activation of counterregulatory hormone and symptom responses to hypoglycemia are impaired, in part due to recurrent episodes of hypoglycemia. Islet transplantation can ameliorate occurrences of hypoglycemia in these patients. OBJECTIVE: The objective of the study was to determine whether the avoidance of hypoglycemia achieved through islet transplantation results in improved glycemic thresholds for counterregulatory responses. SETTING: The study was conducted at a general clinical research center. PARTICIPANTS: Seven islet transplant recipients, six type 1 diabetic, and eight nondiabetic control subjects participated in the study. INTERVENTION: We performed a stepped hyperinsulinemic hypoglycemic clamp and, in 12 subjects, a paired hyperinsulinemic euglycemic clamp to calculate the glycemic thresholds for and magnitude of counterregulatory responses. RESULTS: The glycemic thresholds for all counterregulatory hormone and symptom responses in the islet transplant group were comparable with normal and higher than in the type 1 diabetes group (P < 0.01 for glucagon; P < 0.05 for epinephrine). The magnitude of the glucagon and epinephrine responses in the islet transplant group, although greater than in the type 1 diabetes group (P < 0.05 for both), remained less than normal (P < 0.01 for glucagon; P < 0.05 for epinephrine). The magnitude of GH secretion in the islet transplant group was comparable with normal and greater than in the type 1 diabetes group (P < 0.05). CONCLUSIONS: The glycemic thresholds for activation of counterregulatory hormone and symptom responses appear normal after islet transplantation; however, the magnitudes of the glucagon and epinephrine responses remain impaired.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2006-2426

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 13

  1. Gold, 1994, Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia., Diabetes Care, 17, 697, 10.2337/diacare.17.7.697 · DOI · Paper page
  2. Cryer, 2005, Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes., Diabetes, 54, 3592, 10.2337/diabetes.54.12.3592 · DOI · Paper page
  3. Cranston, 1994, Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes., Lancet, 344, 283, 10.1016/S0140-6736(94)91336-6 · DOI · Paper page
  4. Liu, 1996, Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control., Clin Invest Med, 19, 71
  5. Kessler, 2002, Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation., Diabetes Care, 25, 2256, 10.2337/diacare.25.12.2256 · DOI · Paper page
  6. Geiger, 2005, Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation., Cell Transplantation, 14, 77, 10.3727/000000005783983214 · DOI
  7. Paty, 2006, Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects., Diabetes Technol Ther, 8, 165, 10.1089/dia.2006.8.165 · DOI · Paper page
  8. Rickels, 2005, Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes., Diabetes, 54, 3205, 10.2337/diabetes.54.11.3205 · DOI · Paper page
  9. McGuire, 1976, Effects of arterial versus venous sampling on analysis of glucose kinetics in man., J Appl Physiol, 41, 565, 10.1152/jappl.1976.41.4.565 · DOI · Paper page
  10. Defronzo, 1979, Glucose clamp technique—method for quantifying insulin-secretion and resistance, Am J Physiol, 237, E214
  11. Paty, 2002, Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence., Diabetes, 51, 3428, 10.2337/diabetes.51.12.3428 · DOI · Paper page
  12. Hoeldtke, 1982, Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy., Ann Intern Med, 96, 459, 10.7326/0003-4819-96-4-459 · DOI · Paper page
  13. Defeo, 1989, Demonstration of a role for growth-hormone in glucose counterregulation, Am J Physiol, 256, E835

Cited by

See all 59

Metadata

Authors
Rickels, M. R., Schutta, M. H., Mueller, R., Kapoor, S., Markmann, J. F., Naji, A., & Teff, K. L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2007-03-01
Volume
92
Issue
3
Pages
873-879
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2102280598
Cited by
59
References
19
FWCI
2.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients. https://app.cochat.ai/papers/10.1210/jc.2006-2426
The paper
Rickels, M. R., Schutta, M. H., Mueller, R., Kapoor, S., Markmann, J. F., Naji, A., & Teff, K. L. (2007). Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2006-2426

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.